Naproxen in juvenile chronic polyarthritis.
Open Access
- 1 April 1979
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 38 (2) , 152-154
- https://doi.org/10.1136/ard.38.2.152
Abstract
Naproxen at 10 mg per kg body weight was compared with aspirin at 80 mg per kg body weight in children suffering from juvenile chronic polyarthritis. It was found to be as effective as aspirin, with certainly no more and possibly fewer gastrointestinal side effects. A long-term tolerance study up to 12 months confirmed that naproxed was a satisfactory nonsteroidal anti-inflammatory drug in the management of various types of juvenile chronic arthritis.This publication has 5 references indexed in Scilit:
- Treatment of Juvenile Chronic PolyarthritisClinics in Rheumatic Diseases, 1975
- Naproxen absorption in childrenCurrent Medical Research and Opinion, 1975
- Naproxen. A new non-hormonal anti-inflammatory agent. Studies in rheumatoid arthritis.Annals of the Rheumatic Diseases, 1974
- Ibuprofen in the management of Still's disease.1973
- Prognosis in Still's disease.1959